Google Fit updated with breathing exercises and home screen widgets
Justices Won't Hear States' Appeal Over Planned Parenthood
Say no to raw cookie dough — CDC issues warning
Republic 'will face food shortages' in no-deal Brexit
Oklahomans have died as flu season continues across the country
Trump's New HHS Nominee Is a Former Pharma Executive
15 November 2017, 09:53 | Randall Craig
Trump just nominated this Lebanese-American to join his cabinet
Even President Trump says so.
The nomination of Alex Azar, the former head of Eli Lilly's US operations, shows that Trump was never serious about his promise to stop the pharmaceutical industry from 'getting away with murder'.
"President Trump has nominated in Mr. Azar someone who shares his misguided and factually flawed views on the Affordable Care Act", Woodhouse said.
He also served several years on the board of directors of the Biotechnology Innovation Organization, a drug industry lobbying group, and earlier was general counsel and deputy secretary for Health and Human Services under former Republican President George W. Bush.
Trump famously said pharma is "getting away with murder", and previously crossed party lines to endorse Medicare price negotiations.
Gottlieb's name was one floated for the HHS chief position after former secretary Tom Price resigned in September, but the FDA commissioner said in a Reuters interview he felt he is "most effective" at the drug agency. He also pointed to Eli Lilly raising drug prices by double digits while Azar was an executive at the company.
Critics mocked the selection by a president who promised to drain the Washington "swamp" of lobbyists and has complained about "RIPOFF DRUG PRICES" on Twitter.
Azar's nomination is sure to encounter more pushback. For those opposed to the path Trump has been taking Health and Human Services, Alex Azar symbolizes yet another attack on the progress made by the Affordable Care Act with his policy preferences aimed at undercutting and reversing numerous ACA's provisions.
But Azar's pharmaceutical industry background prompted immediate questions about potential conflicts of interest and criticism from Democrats, who expressed concern about how he will handle Obamacare and whether he will be tough on drug makers.
Thomas Chandy to move SC against HC order
Ticking the minister off, the HC on Tuesday asked how he, as a minister, could petition the court against the government. The LDF entrusted chief minister Pinarayi Vijayan on Sunday to take a decision.
Sandy Hook families launch plea to save gun suit
It is a somewhat novel legal argument the families hope will help them overcome a federal law enacted by U.S. Congress in 2005 to shield gun manufacturers from liability for how their products are used.
UN's General Assembly adopts Olympic Truce
The PyeongChang Olympics are slated to run from February ninth to 25th and the Paralympics from March ninth to 18th of next year. The theme of the General Assembly this year was "Focusing on People".
Trump Hopes Swift Return of UCLA Players Detained in China
The source told ESPN there is surveillance footage of the players shoplifting from three stores inside a high-end retail center. This official indicated that charges against the players have been reduced and that the case is proceeding toward a resolution.
Byron Maxwell signs one-year deal with Seahawks
Davis was signed from Seattle's practice squad, where the team placed him after claiming him on waivers in May. The 29-year-old has gone through a workout with Seattle on Monday morning prior to re-signing with the team.